AI Technology Group Inc. has announced the unregistered sale of equity securities in connection with its acquisition of AVM Biotechnology Inc. As part of the transaction, the company issued 100 common shares to Biomed 360 Solutions Corp., the sole shareholder of AVM. These shares were not registered under the Securities Act of 1933 and are considered restricted securities under Rule 144. The issuance was made in reliance upon exemptions from registration provided by Section 4(a)(2) of the Securities Act.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AI Technology Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-25-009007), on December 17, 2025, and is solely responsible for the information contained therein.
Comments